Home > Research > Disciplines
The programme focuses on seven disciplines.
Genomics
Modelling
Clinical Trials
Epidemiology
The Centre for Epidemic Research and Modelling conducts advanced quantitative research to understand the dynamics and prevention of disease outbreaks and assess the potential impact of interventions.
Its modeling expertise is central to shaping evidence-based policies at both national and regional levels, enabling timely and effective responses to public health challenges. The Centre also serves as a hub for capacity building, offering specialized training in quantitative public health techniques to equip researchers and policymakers with essential skills.
ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID) is a collaborative network of over 100 hospitals across the globe, dedicated to clinical research in infectious diseases. Its goal is to strengthen the evidence base for optimizing patient outcomes for endemic and epidemic infectious diseases, with a focus on antimicrobial resistance (AMR).
Current research initiatives include large-scale AMR surveillance and randomised controlled trials for novel diagnostics and antibiotics. ADVANCE-ID collaborates closely with national governments and international health policy bodies to ensure research findings drive actionable change.
ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID) is a collaborative network of over 100 hospitals across the globe, dedicated to clinical research in infectious diseases. Its goal is to strengthen the evidence base for optimizing patient outcomes for endemic and epidemic infectious diseases, with a focus on antimicrobial resistance (AMR).
Current research initiatives include large-scale AMR surveillance and randomised controlled trials for novel diagnostics and antibiotics. ADVANCE-ID collaborates closely with national governments and international health policy bodies to ensure research findings drive actionable change.
Our research focuses on the economic burden and impact of infectious diseases in Singapore and internationally. We use health technology assessment (HTA) methodologies to evaluate interventions for infectious diseases, ensuring that health policies are informed by evidence. We also organize training programs and symposiums to build capacity in HTA.
The Centre for Epidemic Research and Modelling conducts advanced quantitative research to understand the dynamics and prevention of disease outbreaks and assess the potential impact of interventions.
Its modeling expertise is central to shaping evidence-based policies at both national and regional levels, enabling timely and effective responses to public health challenges. The Centre also serves as a hub for capacity building, offering specialized training in quantitative public health techniques to equip researchers and policymakers with essential skills.
Insights from socio-behavioural studies gives us an understanding of how people make decisions and take actions. We explore human behaviours, social interactions, and motivations through epidemiological quantitative and qualitative approaches to examine diverse public health topics, including COVID-19, maternal and child health, vaccine uptake, and health systems.
The Centre for Epidemic Research and Modelling conducts advanced quantitative research to understand the dynamics and prevention of disease outbreaks and assess the potential impact of interventions.
Its modeling expertise is central to shaping evidence-based policies at both national and regional levels, enabling timely and effective responses to public health challenges. The Centre also serves as a hub for capacity building, offering specialized training in quantitative public health techniques to equip researchers and policymakers with essential skills.
ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID) is a collaborative network of over 100 hospitals across the globe, dedicated to clinical research in infectious diseases. Its goal is to strengthen the evidence base for optimizing patient outcomes for endemic and epidemic infectious diseases, with a focus on antimicrobial resistance (AMR).
Current research initiatives include large-scale AMR surveillance and randomised controlled trials for novel diagnostics and antibiotics. ADVANCE-ID collaborates closely with national governments and international health policy bodies to ensure research findings drive actionable change.
Our research focuses on the economic burden and impact of infectious diseases in Singapore and internationally. We use health technology assessment (HTA) methodologies to evaluate interventions for infectious diseases, ensuring that health policies are informed by evidence. We also organize training programs and symposiums to build capacity in HTA.
Insights from socio-behavioural studies gives us an understanding of how people make decisions and take actions. We explore human behaviours, social interactions, and motivations through epidemiological quantitative and qualitative approaches to examine diverse public health topics, including COVID-19, maternal and child health, vaccine uptake, and health systems.
The Centre for Epidemic Research and Modelling conducts advanced quantitative research to understand the dynamics and prevention of disease outbreaks and assess the potential impact of interventions.
Its modeling expertise is central to shaping evidence-based policies at both national and regional levels, enabling timely and effective responses to public health challenges. The Centre also serves as a hub for capacity building, offering specialized training in quantitative public health techniques to equip researchers and policymakers with essential skills.
ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID) is a collaborative network of over 100 hospitals across the globe, dedicated to clinical research in infectious diseases. Its goal is to strengthen the evidence base for optimizing patient outcomes for endemic and epidemic infectious diseases, with a focus on antimicrobial resistance (AMR).
Current research initiatives include large-scale AMR surveillance and randomised controlled trials for novel diagnostics and antibiotics. ADVANCE-ID collaborates closely with national governments and international health policy bodies to ensure research findings drive actionable change.